Krsnaa Diagnostics' Q3 FY 2025-26 Quarterly Results
- 06 Feb 2026
Result Summary
- Krsnaa Diagnostics Ltd reported a 12.0% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 0.7%.
- Its expenses for the quarter were down by 7.5% QoQ and up 4.4% YoY.
- The net profit decreased 36.3% QoQ and decreased 21.5% YoY.
- The earnings per share (EPS) of Krsnaa Diagnostics Ltd stood at 4.66 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 184.97 | 210.16 | 183.75 | -12.0% | 0.7% |
Total Expenses | 165.21 | 178.62 | 158.27 | -7.5% | 4.4% |
Profit Before Tax | 19.77 | 31.55 | 25.48 | -37.3% | -22.4% |
Tax | 4.44 | 7.62 | 6.06 | -41.7% | -26.7% |
Profit After Tax | 15.25 | 23.94 | 19.42 | -36.3% | -21.5% |
Earnings Per Share | 4.66 | 7.25 | 5.88 | -35.7% | -20.7% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Krsnaa Diagnostics Ltd is a healthcare service provider specializing in diagnostic services. The company operates in the healthcare sector, focusing on delivering a range of diagnostic solutions such as imaging, pathology, and tele-radiology services. Krsnaa Diagnostics is known for its extensive network of diagnostic centers across various locations, making healthcare accessible to a broad patient base. While specific recent major developments were not provided in the data, the company continues to expand its reach and services, contributing to its role in the healthcare industry. The company's operations are aligned with the growing demand for diagnostic healthcare services in the region.
Revenue
In Q3 FY26, Krsnaa Diagnostics Ltd reported a total income of ₹184.97 crores. This represents a decrease of 12.0% compared to the previous quarter (Q2 FY26), where the total income was ₹210.16 crores. However, when compared to the same quarter in the previous year (Q3 FY25), where the total income was ₹183.75 crores, there is a slight increase of 0.7%. The quarter-over-quarter decline in total income reflects a decrease in revenue generation during the current quarter, while the year-over-year change indicates a relatively stable revenue performance compared to the previous year.
Profitability
The company's profitability metrics for Q3 FY26 show a profit before tax of ₹19.77 crores, which is a significant decrease of 37.3% from Q2 FY26's profit before tax of ₹31.55 crores. Year-over-year, this figure has decreased by 22.4% from ₹25.48 crores in Q3 FY25. The profit after tax for Q3 FY26 stands at ₹15.25 crores, down by 36.3% from ₹23.94 crores in Q2 FY26 and by 21.5% from ₹19.42 crores in Q3 FY25. Earnings per share also reflect this decline, with Q3 FY26 EPS at ₹4.66, down from ₹7.25 in the previous quarter and ₹5.88 in the same quarter last year. These figures indicate lower profitability in the current quarter compared to both the previous quarter and the corresponding quarter of the prior year.
Operating Metrics
The total expenses for Krsnaa Diagnostics Ltd in Q3 FY26 were ₹165.21 crores, marking a 7.5% decrease from Q2 FY26's total expenses of ₹178.62 crores. However, there is a 4.4% increase in expenses compared to Q3 FY25, where the expenses were ₹158.27 crores. The tax expense for the current quarter is ₹4.44 crores, showing a reduction of 41.7% from Q2 FY26's tax of ₹7.62 crores and a 26.7% decrease from ₹6.06 crores in Q3 FY25. These operational metrics highlight a reduction in expenses and tax obligations quarter-over-quarter, while year-over-year, there is a slight increase in total expenses alongside a decrease in tax payments.